Joanna Banatkiewicz

Joanna Banatkiewicz

Auto-generated profile, based on publicly available information

Joanna Banatkiewicz

Medical University of Warsaw

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 May 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
SCSofia Czarnecka
Sofia Czarnecka
GŁGabriela Łuczyńska
Gabriela Łuczyńska
JBJoanna Banatkiewicz
Joanna Banatkiewicz
EDEmilia Deka
Emilia Deka
JDJan Domińczak
Jan Domińczak
AWAntoni Wojnowski
Antoni Wojnowski
Attention-deficit/hyperactivity disorder (ADHD) is a prevalent neurodevelopmental disorder in children and adolescents and is associated with substantial functional impairment. Although psychostimulants are considered first-line pharmacotherapy, a significant proportion of patients experience inadequate response, poor tolerability, or contraindications to stimulant use. Consequently, non-stimulant medications remain an important component of ADHD management. Guanfacine extended release (GXR), a selective α2A-adrenergic receptor agonist, is approved for the treatment of pediatric ADHD and represents a well-established non-stimulant option. Evidence derived from randomized controlled trials, meta-analyses, and systematic reviews indicates that GXR is effective as monotherapy and as adjunctive therapy to psychostimulants in children and adolescents aged 6–17 years. Across studies, GXR demonstrates clinically meaningful reductions in core ADHD symptoms compared with placebo, with reported effect sizes generally ranging from 0.5 to 0.8. The most commonly reported adverse events are sedation-related symptoms, including somnolence and fatigue, which are typically mild to moderate and tend to decrease with ongoing treatment. Cardiovascular effects are usually modest and consist mainly of small reductions in blood pressure and heart rate, with clinically significant events occurring infrequently. Overall, available data indicate that guanfacine extended release is an effective and generally well-tolerated non-stimulant treatment for ADHD in pediatric and adolescent populations. Its clinical utility is particularly relevant in patients with insufficient response or intolerance to stimulants, as well as in those requiring adjunctive pharmacotherapy. Further studies are warranted to evaluate long-term outcomes and to better define its comparative effectiveness in specific clinical subgroups.

18 April 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
JDJan Domińczak
Jan Domińczak
ADAdam Dobosz
Adam Dobosz
AWAntoni Wojnowski
Antoni Wojnowski
SCSofia Czarnecka
Sofia Czarnecka
GŁGabriela Łuczyńska
Gabriela Łuczyńska
OBOliwia Bartkowska
Oliwia Bartkowska
Introduction and purpose. Articular cartilage injuries represent a significant clinical challenge due to the tissue’s limited intrinsic healing capacity, often progressing to osteoarthritis and chronic disability. Traditional treatments remain largely symptomatic, prompting extensive research into regenerative therapies aimed at restoring functional cartilage tissue. Description of the state of knowledge. We conducted a systematic analysis of recent literature (2020-2026) encompassing randomized controlled trials, systematic reviews, meta-analyses, and prospective cohort studies. Evidence was synthesized across multiple therapeutic modalities including mesenchymal stem cells (MSCs), autologous chondrocyte implantation (ACI/MACI), platelet-rich plasma (PRP), osteochondral transplantation, tissue engineering scaffolds, and emerging technologies such as 3D bioprinting, gene therapy, and exosome-based treatments. Matrix-associated autologous chondrocyte implantation (MACI) demonstrates significant long-term efficacy with large effect sizes (>0.8) in patient-reported outcomes at 2-15 years follow-up. Mesenchymal stem cells from various sources (bone marrow, adipose tissue, synovium, umbilical cord) show promise in clinical trials, with synovium-derived MSCs exhibiting particularly high chondrogenic potential. Comparative studies indicate that ACI/MACI and expanded MSC transplantation outperform microfracture for focal cartilage defects. Summary. Regenerative therapies have evolved significantly, with cell-based approaches demonstrating superior outcomes compared to traditional marrow stimulation techniques. However, challenges persist regarding optimal cell source, dosage, delivery methods, and long-term durability. Standardized protocols, large-scale randomized trials, and integration of emerging technologies are essential to advance the field toward personalized, effective cartilage regeneration strategies.

19 April 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
KBKarolina Babik
Karolina Babik
OBOliwia Bartkowska
Oliwia Bartkowska
JBJoanna Banatkiewicz
Joanna Banatkiewicz
EDEmilia Deka
Emilia Deka
JDJan Domińczak
Jan Domińczak
HBHanna Maria Bojanowska
Hanna Maria Bojanowska
Obesity is currently recognized as a chronic, relapsing and progressive disease, constituting one of the most serious public health challenges of the 21st century. The introduction of glucagon-like peptide-1 receptor agonists (GLP-1 RAs), such as semaglutide and tirzepatide, has led to unprecedented therapeutic success, enabling weight reduction comparable to that achieved by bariatric surgery. However, despite their high efficacy, discontinuation of these agents is associated with rapid and clinically significant weight regain. The aim of this paper is to analyze the physiological mechanisms responsible for post-treatment weight regain following GLP-1 analogue withdrawal and to evaluate the effectiveness of selected strategies aimed at limiting this phenomenon, with particular emphasis on resistance training, nutritional interventions and pharmacological deprescribing models. Available clinical and experimental data indicate that weight regain is driven primarily by metabolic adaptation, including a disproportionate reduction in resting metabolic rate, loss of lean body mass and dysregulation of appetite-controlling hormones. Evidence from major clinical trials (STEP, SURMOUNT) confirms that up to two-thirds of the lost body weight may be regained within one year after cessation of therapy. The findings highlight the necessity of treating obesity pharmacotherapy as part of a long-term management strategy. Integration of pharmacological treatment with resistance training, high-protein dietary patterns and gradual dose reduction protocols appears essential for sustaining therapeutic effects and preventing the rebound phenomenon.

28 March 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
OBOliwia Bartkowska
Oliwia Bartkowska
JBJoanna Banatkiewicz
Joanna Banatkiewicz
EDEmilia Deka
Emilia Deka
JDJan Domińczak
Jan Domińczak
SCSofia Czarnecka
Sofia Czarnecka
HBHanna Maria Bojanowska
Hanna Maria Bojanowska
BACKGROUND: Sleep is recognized as a key factor influencing athletic performance and injury prevention. Despite growing interest in sleep as a modifiable risk factor, the relationship between sleep parameters and the risk of sports injuries requires systematic evaluation. AIM: This study focuses on presenting the relationship between the duration, quality and patterns of sleep and the occurrence and prevention of sports injuries based on current knowledge. MATERIAL AND METHODS: This systematic review was conducted using multiple databases, including ScienceDirect, PubMed and Google Scholar. After removing duplicates, 165 unique articles compatible with the study topic were identified. The 31 most relevant articles were selected and used to analyse the association between sleep parameters and the effects of sports injuries in athlete populations. RESULTS: Strong evidence has been identified linking insufficient sleep to an increased risk of sports injuries in many groups of athletes. In addition, the study confirmed that poor sleep quality was associated with a significantly higher likelihood of injury. The study confirmed mechanisms connecting sleep and injury include impaired cognitive function, slowed reaction time, weakened neuromuscular control, increased inflammation and impaired tissue regeneration. CONCLUSIONS: Evidence shows that sleep has a protective effect against injuries when it is sufficiently long and of adequate quality. Healthcare professionals, coaches and athletes should prioritise sleep hygiene measures as part of comprehensive injury prevention strategies.

24 September 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
GŁGabriela Łuczyńska
Gabriela Łuczyńska
JBJoanna Banatkiewicz
Joanna Banatkiewicz
SCSofia Czarnecka
Sofia Czarnecka
AWAntoni Wojnowski
Antoni Wojnowski
JDJan Domińczak
Jan Domińczak
OBOliwia Bartkowska
Oliwia Bartkowska
Introduction: The menstrual cycle involves a complex interaction of hormonal fluctuations that can influence various aspects of female athletic performance. Understanding these relationships has become increasingly important for optimizing training programs and supporting female athletes across different competitive levels. Objective: This review synthesizes current evidence on how menstrual cycle phases and hormonal contraception affect physical performance in female athletes. Material and methods: We conducted a comprehensive literature search across major databases including PubMed, Web of Science, and SPORTDiscus, focusing on studies published between 2020 and 2025 that examined menstrual cycle effects on athletic performance. Conclusions: Current evidence suggests that menstrual cycle phase effects on performance are generally small and highly individualized. While some athletes do experience performance decrements during specific phases particularly the early follicular and late luteal phases, group-level effects are often minimal or inconsistent. Interestingly, perceptual symptoms and psychological well-being appear to influence performance more consistently than hormonal fluctuations alone. Hormonal contraception shows variable effects depending on type and formulation. Rather than applying universal cycle-based training modifications, we recommend individual monitoring and personalized approaches.

15 May 2026 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
HBHanna Bojanowska
Hanna Bojanowska
GŁGabriela Łuczyńska
Gabriela Łuczyńska
JBJoanna Banatkiewicz
Joanna Banatkiewicz
EDEmilia Deka
Emilia Deka
JDJan Domińczak
Jan Domińczak
AWAntoni Wojnowski
Antoni Wojnowski
Background: In modern sports, the line between healthy dedication and unhealthy obsession is becoming increasingly blurred. While classic eating disorders like anorexia and bulimia are well-known, Orthorexia Nervosa (ON) and Muscle Dysmorphia (MD) are growing problems that affect athletes of all genders but often go unnoticed. Objective: This review summarizes current knowledge regarding the prevalence, causes, and health consequences of ON and MD in athletes, based on literature acquired from PubMed, Embase, and Web of Science. Results: Evidence clearly shows that athletes are at a much higher risk for both conditions compared to the general population. Because strict diets and constant body monitoring are considered "normal" in sports, these disorders are often difficult to spot. Key risk factors include perfectionistic personality traits, pressure to meet weight requirements in certain sports, and the influence of social media, which promotes unrealistic body standards. Conclusion: Both ON and MD can lead to serious physical health issues, such as Relative Energy Deficiency in Sport (RED-S). Current findings highlight an urgent need for better screening tools designed specifically for athletes. Furthermore, a significant change in how we educate athletes and coaches about mental health and nutrition is necessary.